Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Emily Jochim"'
Autor:
Nazila Salamat-Miller, Mark A. Turner, Amey Bandekar, Nitin Dixit, Emily Jochim, Barry Mangum, Christopher McPherson, Srini Tenjarla, Sukhjeet Singh, You Seok Hwang, Norman Barton
Publikováno v:
World journal of pediatrics : WJP.
Background Recombinant human (rh)IGF-1/IGFBP-3 protein complex, administered as a continuous intravenous infusion in preterm infants, is being studied for the prevention of complications of prematurity. Methods We conducted in vitro studies to evalua
Autor:
Norman W. Barton, Ajit Mahaveer, Luca A. Ramenghi, Ingrid Hansen-Pupp, Faizah Bhatti, Jason Higginson, Emily Jochim, Alexandra Mangili, Boubou Hallberg, Carlo Dani, Mirjam M. van Weissenbruch, David Ley, Peter Reynolds, Jou Ku Chung, Olachi J. Mezu-Ndubuisi, Lois E.H. Smith, Mark A. Turner, Ann Hellström, Kathryn Beardsall, Neil Marlow, Mohamed Hamdani, Adina Tocoian, Carmen Giannantonio, David B. Dunger
Publikováno v:
The Journal of pediatrics
Ley, D, Hallberg, B, Hansen-Pupp, I, Dani, C, Ramenghi, L A, Marlow, N, Beardsall, K, Bhatti, F, Dunger, D, Higginson, J D, Mahaveer, A, Mezu-Ndubuisi, O J, Reynolds, P, Giannantonio, C, van Weissenbruch, M, Barton, N, Tocoian, A, Hamdani, M, Jochim, E, Mangili, A, Chung, J-K, Turner, M A, Smith, L E H & Hellström, A 2019, ' rhIGF-1/rhIGFBP-3 in Preterm Infants: A Phase 2 Randomized Controlled Trial ', Journal of Pediatrics, vol. 206, pp. 56-65.e8 . https://doi.org/10.1016/j.jpeds.2018.10.033
Journal of Pediatrics, 206, 56-65.e8. Mosby Inc.
Ley, D, Hallberg, B, Hansen-Pupp, I, Dani, C, Ramenghi, L A, Marlow, N, Beardsall, K, Bhatti, F, Dunger, D, Higginson, J D, Mahaveer, A, Mezu-Ndubuisi, O J, Reynolds, P, Giannantonio, C, van Weissenbruch, M, Barton, N, Tocoian, A, Hamdani, M, Jochim, E, Mangili, A, Chung, J-K, Turner, M A, Smith, L E H & Hellström, A 2019, ' rhIGF-1/rhIGFBP-3 in Preterm Infants: A Phase 2 Randomized Controlled Trial ', Journal of Pediatrics, vol. 206, pp. 56-65.e8 . https://doi.org/10.1016/j.jpeds.2018.10.033
Journal of Pediatrics, 206, 56-65.e8. Mosby Inc.
Objective: To investigate recombinant human insulin-like growth factor 1 complexed with its binding protein (rhIGF-1/rhIGFBP-3) for the prevention of retinopathy of prematurity (ROP) and other complications of prematurity among extremely preterm infa